Shows
Parallax by Ankur KalraEP 117: Transforming Cardiac Surgery Recovery: Evidence-Based Insights with Dr GerdischThis week on Parallax, Dr Ankur Kalra welcomes Dr Marc Gerdisch to discuss a groundbreaking study on reducing opioid use after cardiac surgery.
Dr Marc Gerdisch is the Chief of Cardiovascular and Thoracic Surgery and Co-Director of the Heart Valve Center and Atrial Fibrillation Program at Franciscan St. Francis Health. He is a senior partner at Cardiac Surgery Associates and a Clinical Assistant Professor of Thoracic and Cardiovascular Surgery at Loyola University Medical Center in Chicago.
Dr Gerdisch shares insights into his research on rigid sternal fixation and enhanced recovery protocols, which have shown promising results in postoperative pain management...
2024-08-1240 min
Parallax by Ankur KalraThe Leap Year Gene of Kit McKinley with Shelley Wood, Bestselling Author & Editor-in-Chief of TCTMDIn this week’s Parallax, Dr Ankur Kalra welcomes back Shelley Wood, best known for her work in the cardiology community as the editor-in-chief of TCTMD and Editorial Director of CRF. They discuss her work as a creative author and her second novel, "The Leap Year Gene of Kit McKinley " set to be published by Harper Collins in Canada and Union Square Press in the US in August 2024.
Blending the intrigue of a medical thriller with a sweeping overview of the twentieth century, "The Leap Year Gene of Kit McKinley" tells the story of Kit McKinley, whose rare genetic condition ca...
2024-06-1742 min
2022-11-2307 min
Parallax by Ankur KalraEP 71: Cardiology News, Journalism & Leadership with Shelley WoodIn 1999, when Shelley Wood started her career in medical journalism, there were only a few online resources. The main function of reporting on medical news was to make information accessible. Two decades later there is an abundant number of sources covering cardiology news, but TCTMD, home of Ms Wood, stands out with its “lively, thought-provoking, and rigorously objective journalism”.1
This week’s guest on Parallax is Shelley Wood, Managing Editor of TCTMD, Editorial Director at CRF and 2022 recipient of the Women Heart’s Wenger Award for Excellence in Media.
In this engaging episode, Ankur asks Shelley about her journey to medical...
2022-06-0649 min
MedAxiom HeartTalkStructural Heart Innovations: PEARLS Paper Part 2On MedAxiom HeartTalk, we are diving deeper with part two on the PEARLS Paper - a blueprint structural heart programs can use to optimize care. Host, Melanie Lawson, speaks with Elizabeth Perpetua, DNP, ACNP-BC, FACC, Patricia Keegan, DNP, NP-C, AACC, Roseanne Palmer, MSN, RN, and Susan Schnell, MSN, ACNP-BC, all co-authors of the paper. They share how their geographical challenges influenced their perspectives writing the paper and discuss practical steps that organizations can take now, to implement guidelines and care pathways for future crises.Guest Bios: Elizabeth Perpetua, DNP, ACNP-BC, FACC: Founder of Empath Health Services an...
2022-05-3141 minTalking PointsEpisode 133: The COBRA-REDUCE TrialRobert Byrne and C. Michael Gibson discuss a randomized trial of a thromboresistant Polyzene F-coated stent with 14-day DAPT in high-bleeding-risk patients.
2021-12-0209 minTalking PointsEpisode 132: The RIVER TrialOtavio Berwanger and C. Michael Gibson discuss rivaroxaban versus warfarin in patients with bioprosthetic mitral valves and atrial fibrillation or flutter.
2021-11-1008 minTalking PointsEpisode 131: The SCOPE II TrialCorrado Tamburino and C. Michael Gibson discuss a randomized trial of two self-expanding TAVR bioprostheses.
2021-11-0310 minTalking PointsEpisode 130: The DISRUPT CAD III TrialDean Kereiakes and C. Michael Gibson discuss intravascular lithotripsy for the treatment of severe coronary calcification.
2021-10-2017 minTalking PointsEpisode 129: The TICO-STEMI TrialByeong-Keuk Kim and C. Michael Gibson discuss a randomized trial of ticagrelor monotherapy versus ticagrelor with aspirin in STEMI.
2021-10-0608 minTalking PointsEpisode 128: The COMPARE CRUSH TrialGeorgios Vlachojannis and C. Michael Gibson discuss a randomized trial of prehospital crushed versus uncrushed prasugrel in STEMI.
2021-09-2209 minTalking PointsEpisode 127: The SOLOIST-WHF and SCORED TrialsDeepak Bhatt and C. Michael Gibson discuss data on sotagliflozin in diabetes.
2021-09-0816 minTalking PointsEpisode 126: The REFLECT II TrialJeffrey Moses and C. Michael Gibson discuss a randomized trial of cerebral embolic protection during TAVR.
2021-08-2508 minTalking PointsEpisode 125: The TIPS-3 TrialSalim Yusuf and C. Michael Gibson discuss aspirin alone and in combination with a polypill for CVD primary prevention.
2021-08-1809 minTalking PointsEpisode 124: The MITHRAS TrialPhilipp Lurz and C. Michael Gibson discuss a randomized trial of ASD closure after TMVr.
2021-08-0403 minTalking PointsEpisode 123: The XIENCE 90/28 TrialRoxana Mehran and C. Michael Gibson discuss 3-month and 1-month DAPT after everolimus-eluting stents in high-bleeding-risk patients.
2021-07-2110 minTalking PointsEpisode 122: The MSTOPS TrialSteven Steinhubl and C. Michael Gibson discuss 3-year outcomes in a nationwide, randomized, pragmatic clinical trial of A-fib screening.
2021-07-0706 minTalking PointsEpisode 121: The TARGET FFR TrialDamien Collison and C. Michael Gibson discuss a randomized trial of physiology-guided PCI optimization.
2021-06-2308 minTalking PointsEpisode 120: The STRENGTH TrialA. Michael Lincoff and C. Michael Gibson discuss CV outcomes with omega-3 carboxylic acids in patients with high vascular risk and atherogenic dyslipidemia.
2021-06-1611 minTalking PointsEpisode 119: The STRENGTH TrialA. Michael Lincoff and C. Michael Gibson discuss CV outcomes with omega-3 carboxylic acids in patients with high vascular risk and atherogenic dyslipidemia.
2021-06-0211 minTalking PointsEpisode 118: The OPTIMIZE TrialDean Kereiakes and C. MIchael Gibson discuss a randomized trial of a novel, ultra-low-profile fixed-wire DES.
2021-05-1910 minTalking PointsEpisode 117: The AHA COVID-19 CVD RegistryRobert Harrington and C. Michael Gibson discuss the registry's design, implementation, and initial results.
2021-05-0615 min
No Pills, No Hunger#26 What is the Life Expectancy of a Type 2 Diabetic?We all hope for a long, healthy life. If you have Type 2 Diabetes that goes unmanaged, there is a chance you will have a shorter life expectancy ... some studies state by 2 years, other by 10 years. However, maybe the question that should be considered is not how many years of life but what will those years look like for me. Will I be able to do the things I love or will Type 2 diabetes and it's complications limit me? In this episode, you are encouraged to take action and make dietary changes that can help you improve your quality of life...
2021-04-2219 minTalking PointsEpisode 116: The TANGO TrialEhrin Armstrong and C. Michael Gibson discuss a randomized, dose-escalation trial of temsirolimus adventitial delivery below the knee.
2021-04-2106 minTalking PointsEpisode 115: The GALACTIC-HF TrialJohn Teerlink and C. Michael Gibson discuss omecamtiv mecarbil in chronic HFrEF.
2021-04-0714 minTalking PointsEpisode 114: The NACMI COVID-19 RegistryTimothy Henry and C. Michael Gibson discuss outcomes from the North American registry.
2021-03-2428 minTalking PointsEpisode 113: The EXPLORER-HCM TrialIacopo Olivotto and C. Michael Gibson discuss mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.
2021-03-1710 minTalking PointsEpisode 112: FLASH Registry: Acute Hemodynamic ImprovementC. Michael Gibson and Catalin Toma discuss acute hemodynamic improvement with percutaneous mechanical thrombectomy in a real-world pulmonary embolism population.
2021-03-0306 minTalking PointsEpisode 111: The PARALLAX TrialBurkert Pieske and C. Michael Gibson discuss sacubitril/valsartan versus individualized RAAS blockade in HFpEF.
2021-02-1709 minTalking PointsEpisode 110: The HOME-PE TrialPierre-Marie Roy and C. Michael Gibson discuss hospitalization or outpatient management of PE.
2021-02-0309 minTalking PointsEpisode 109: The EAST-AFNET 4 TrialPaulus Kirchhof and C. Michael Gibson discuss early rhythm control therapy in patients with atrial fibrillation.
2021-01-2014 minTalking PointsEpisode 108: The BPLTTC TrialKazem Rahimi and C. Michael Gibson discuss BP-lowering for prevention of cardiovascular events.
2021-01-0605 minTalking PointsEpisode 107: LoDoCo2 Low-Dose Colchicine in Coronary DiseaseDr. Jan Cornel and Dr. C. Michael Gibson Discuss: LoDoCo2 Low-Dose Colchicine in Coronary Disease.
2020-12-1607 minTalking PointsEpisode 106: TCT Connect 2020C. Michael Gibson, Ajay Kirtane, Mamas Mamas, and Roxana Mehran talk TCT 2020.
2020-12-0228 min
Wellness Your Way with Dr. Megan LyonsThe Importance of RestThis episode covers:A study comparing sugar sweetened beverages to artificially sweetened beveragesA product recommendation for my favorite cauliflower dipHow to rest your mind, body, and soulTwo Q and As giving you tips for reducing plastic use and for staying hydrated in the winter Links I mentioned during this episode:Artificially sweetened drinks vs sugar sweetened drinks study: https://www.jacc.org/doi/full/10.1016/j.jacc.2020.08.075. Article on above study: https://www.tctmd.com/news/both-sugary-and-artificially-sweetened-drinks-linked-cvd. Cauliflower dip at Kroger: https://www.kroger.com/p/simple-truth-plant-based-cilantro-with-jalapeno-cauliflower-dip/0001111004723Cauliflower dip recipe: https://www.epicurious.com...
2020-11-1032 minTalking PointsEpisode 105: POPULAR TAVIC. Michael Gibson and Jorn Brouwer discuss aspirin with or without clopidogrel after transcatheter aortic valve replacement.
2020-11-0406 minTalking PointsEpisode 104: EMPEROR ReducedC. Michael GIbson and Milton Packer Discuss empagliflozin in heart failure with reduced ejection fraction.
2020-10-2116 minTalking PointsEpisode 103: New ESC NSTEMI GuidelinesC. Michael Gibson and Roxana Mehran discuss new ESC NSTEMI guidelines and more
2020-10-0709 minTalking PointsEpisode 102: Innovation in Mitral Valve RepairC. Michael Gibson and Steven Goldberg discuss REDUCE-FMR and sham-controlled trials in MV repair.
2020-09-0202 minTalking PointsEpisode 101: PARTNER 2A: 5-Year OutcomesC. Michael Gibson and Vinod Thourani discuss 5-year outcomes in this randomized trial of TAVR vs SAVR in intermediate-risk patients.
2020-08-1902 minTalking PointsEpisode 100: COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3Suzanne Baron and C. Michael Gibson discuss important new details from these two structural heart disease trials.
2020-08-0505 minTalking PointsEpisode 99: EVOLVE Short DAPT: 3-Month DAPT in PatientsC. Michael Gibson and Ajay Kirtane review the results of this single-arm stent study.
2020-07-2202 minTalking PointsEpisode 98: #WomenAs1: The Battle for Gender EqualityRoxana Mehran brings C. Michael Gibson up to speed on a campaign to promote talent in medicine by offering professional opportunities to female physicians.
2020-07-1506 minTalking PointsEpisode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus AspirinUsman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.
2020-07-0204 minTalking PointsEpisode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCIC. Michael Gibson and Myeong-Ki Hong discuss 5-year outcomes in this randomized trial.
2020-06-1705 minTalking PointsEpisode 95: FORZA: Randomized Trial of Fractional Flow ReserveWhat are the respective values of FFR and OCT in guiding revascularization? C. Michael Gibson gets a primer from Francesco Burzotta.
2020-05-2005 minTalking PointsEpisode 94: Wearables - The Future Is NowC. Michael Gibson connects with Sameer Mehta and Francisco Fernandez to hear how new tech is poised to disrupt medical care.
2020-04-2206 minTalking PointsEpisode 93: Onyx ONEC. Michael Gibson learns about the Onyx ONE trial from Stephan Windecker.
2020-04-1707 minTalking PointsEpisode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus AspirinC. Michael Gibson reviews the randomized TWILIGHT trial results with Roxana Mehran.
2020-04-0105 minTalking PointsEpisode 91: Propensity Score-Matched AnalysisMaurizio Taramasso walks C. Michael Gibson through randomized data focused on tricuspid valve disease.
2020-03-1804 minTalking PointsEpisode 90: MODEL U-SES: 3-Month DAPT in Patients at High Bleeding RiskC. Michael Gibson hears from Ken Kozuma about the single-arm MODEL U-SES study.
2020-03-0403 min
The Stronger By Science PodcastAntioxidants, Injury Risk Factors, and the Conjugate MethodWe’re back with a new episode after a week of exhausting President’s Day and National Sticky Bun Day celebrations. In today’s episode, Greg shares some Feats of Strength, along with an announcement about how to participate in a Reddit Program Party featuring his new program, Average to Savage 2.0. This episode also features discussions about two new articles on the website; one article discusses everything lifters would want to know about antioxidants, and the other discusses which factors influence injury risk in powerlifters. After that, we discuss some research about muscle protein synthesis and links between artificial sweete...
2020-02-271h 58Talking PointsEpisode 89: STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the USVinay Badhwar discusses new data from the STS Registry addressing volume/outcome relationships for mitral valve surgery.
2020-02-2408 min
Talking PointsEpisode 88: Mitral Valve-in-Valve: 1-Year OutcomesC. Michael Gibson discusses 1-year results from this high-risk patient series with Mayra Guerrero.
2020-02-0500 minTalking PointsEpisode 87: SCOPE I: ACURATE Neo vs SAPIEN 3 in Severe Aortic StenosisJonas Lanz walks C. Michael Gibson through the main results from this head-to-head TAVR trial.
2020-01-2200 minTalking PointsEpisode 86: REMEDIAL III: Urine Flow Rate-Guided vs LVEDP-Guided HydrationC. Michael Gibsons sits down with Carlo Briguori to discuss the REMEDIAL III trial results.
2020-01-1604 min
Heart to Heart with AnnaDoctor Burnout in the Congenital Heart Defect CommunityDoctor Burnout is not a new phenomenon but this episode of Heart to Heart with Anna tackles the topic from a unique perspective. How can members of the congenital heart defect (CHD) community come together to acknowledge that doctor burnout does exist and work together to offer some solutions to reduce some of the stress? Dr. Ami Bhatt and Dr. William Novick join Anna to discuss this important topic. What shift in framework is being taught to residents and fellows in some parts of the United States? What changes in the field of medicine in the last 20 years...
2020-01-1439 minTalking PointsEpisode 85: REDUCE-FMR: Percutaneous Mitral Annuloplasty in Functional Mitral RegurgitationSamir Kapadia, Horst Sievert, and C. Michael Gibson discuss this randomized sham-controlled trial of the Carillon device.
2020-01-0706 minTalking PointsEpisode 84: A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMIC. Michael Gibson and Dean Kereiakes discuss the first human use of RUC-4, designed for STEMI point-of-care treatment.
2019-12-1807 minTalking PointsEpisode 83: The Medically Ill Patients in AUGUSTUSC. Michael Gibson discusses the AUGUSTUS trial with Renato Lopes.
2019-12-0403 minTalking PointsEpisode 82: EXCEL: 5-Year OutcomesC. Michael Gibson speaks with Gregg Stone about EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease.
2019-11-2009 minTalking PointsEpisode 81: COAPT 3-Year OutcomesC. Michael Gibson speaks with Michael Mack about the COAPT Trial 3-year outcomes and results.
2019-11-0604 minTalking PointsEpisode 80: PARTNER 3 Low-Risk Computed Tomography SubstudyC. Michael Gibson speaks with Raj Makkar about PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves
2019-10-2505 minTalking PointsEpisode 79: LEVANT: 5-Year Outcomes From Three Randomized TrialsC. Michael Gibson speaks with Kenneth Ouriel about LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease
2019-10-1604 minTalking PointsEpisode 78: REDUCE-FMR: A Sham-Controlled Randomized TrialC. Michael Gibson sits down with Horst Sievert to learn more about the REDUCE-FMR trial.
2019-09-1802 minTalking PointsEpisode 77: PREPARE-CALC: High-speed Rotational Atherectomy Prior to Drug-Eluting Stent ImplantationC. Michael Gibson gets the details on PREPARE-CALC from Gert Richardt.
2019-09-0404 minTalking PointsEpisode 76: Annapoorna Kini: Clinician, Researcher, Educator, and App DeveloperC. Michael Gibson learns more about Annapoorna Kini's work and why the field needs female role models.
2019-08-2206 minTalking PointsEpisode 75: CorMicA: A Randomized Trial of Invasive Coronary Function TestingC. Michael Gibson and Tom Ford discuss the potential for finding and treating patients with ANOCA.
2019-08-0708 minTalking PointsEpisode 74: Quality of Life in the COAPT StudyC. Michael Gibson and David Cohen discuss adding years to life and adding life to years with the MitraClip.
2019-07-2408 minTalking PointsEpisode 73: COMPARE ABSORBC. Michael Gibson and Pieter Smits walk us through the COMPARE ABSORB trial.
2019-07-1702 minTalking PointsEpisode 72: NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart ValvesC. Michael Gibson and Azeem Latib take a closer look at some next-gen TAVR devices.
2019-07-0305 minTalking PointsEpisode 71: ULTIMATE: A Randomized Trial of Intravascular Ultrasound GuidanceC. Michael Gibson and Junjie Zhang discuss ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population.
2019-06-1804 minTalking PointsEpisode 70: FAST-FFR: Accuracy of Fractional Flow Reserve Derived From Coronary AngiographyC. Michael Gibson and William Fearon talk FFR-CT.
2019-06-0505 minTalking PointsEpisode 69: SOLVE-TAVI: A 2x2 Randomized Trial of Transcather Aortic Valve ImplantationC. Michael Gibson and Holger Thiele take a deep dive into a head-to-head trial of TAVR devices that also considered general versus local anesthesia.
2019-05-2407 minTalking PointsEpisode 68: TALENT: A Randomized TrialC. Michael Gibson talks with Patrick Serruys about, TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population."
2019-05-1506 minTalking PointsEpisode 67: RESET: Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting StentsC. Michael Gibson and Hiroki Shiomi look at long-term outcomes from RESET.
2019-05-0104 minTalking PointsEpisode 66: PORTICO I: One-Year OutcomesC. Michael Gibson and Lars Sondergaard discuss 1-year outcomes in the PORTICO I trial.
2019-04-1703 minTalking PointsEpisode 65: SECURE-PCI: Impact of Timing of Atorvastatin Loading DoseDoes timing of an atorvastatin loading dose make a difference in PCI for ACS? C. Michael Gibson and Renato Lopes discuss.
2019-04-0304 minTalking PointsEpisode 64: Building a New Backbone Upon Which to Randomize Patients: PERT RegistryC. Michael Gibson, Kenneth Rosenfield, and Robert Lookstein discuss the way forward for PERT.
2019-03-2010 minTalking PointsEpisode 63: TRIVALVE: Evaluation of Edge-to-Edge Valve RepairC. Michael Gibson and Jörg Hausleiter discuss the TRIVALVE trial.
2019-03-0603 min
Breaking TrailShelley Wood on Staying Loyal to Your Dream"Blogging is like going to the word gym. I practice writing in the same I would go to a gym to get stronger muscles. Writing is a muscle and I try to stay fit for it. " Is it possible to strive to be a writer and make a living at it? Shelley knew she wanted to be a writer at a young age but how could she make a living doing it? Today is all about making dreams happen. Shelley quit her job, moved to France for a short period and wrote a book. By t...
2019-03-0137 minTalking PointsEpisode 62: BIONYX: A Randomized TrialC. Michael Gibson and Clemens von Birgelen discuss the BIONYX randomized trial.
2019-02-2005 minTalking PointsEpisode 61: ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting StentC. Michael Gibson and Pieter Stella discuss ReCre8, which evaluated a polymer-free DES in an all-comers population.
2019-02-0603 minTalking PointsEpisode 60: What Do You Get When You Combine Twitter and a Textbook? TweetbookWhat do you get when you combine Twitter and a textbook? C. Michael Gibson talks with Michael Savage and David Fischman.
2019-01-2303 minTalking PointsEpisode 59: IMPERIAL: A Randomized Trial of Drug-Eluting StentsC. Michael Gibson talks to William Gray about IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions.
2019-01-0903 minTalking PointsEpisode 58: 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCIC. Michael Gibson speaks with Dominick Angiolillo about the 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI.
2019-01-0204 minTalking PointsEpisode 47: INTREPIDEarly results with a new device being developed for transcatheter MV replacement are promising, Paul Sorajja tells C. Michael Gibson.
2018-06-0703 minTalking PointsEpisode 46: DAPT-STEMIC. Michael Gibson gets the details from DAPT-STEMI from Elvin Kedhi.
2018-05-1805 minTalking PointsEpisode 34: TRACERTRACER: 6-Month Outcomes of Transcatheter MV Neochordal Repair in Patients With Severe Primary Mitral Regurgitation
2018-01-0804 minTalking PointsEpisode 35: TENDYNE TrialDr. C. Michael Gibson talks to Dr. David W. M. Muller about TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation
2018-01-0803 minTalking PointsEpisode 33: DKCRUSH-V TrialDr. C. Michael Gisbon talks to Dr. Shao-Liang Chen about the DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions.
2017-12-0603 minTalking PointsEpisode 31: PLATINUM DIVERSITY - Outcomes With Coronary Stenting in Women and MinoritiesC. Michael Gibson reviews new registry results with Wayne Batchelor.
2017-12-0608 minTalking PointsEpisode 32: COLORListen to C. Michael Gibson in conversation with Giora Weisz.
Color: A Multicenter Registry Looking at Lipid-Rich Plaque & 2-Year Outcomes After Stenting
2017-11-3008 minTalking PointsEpisode 30: PARTNER 2 Quality of LifeC. Michael Gibson discusses health-status benefits in intermediate-risk patients treated with surgical or transcatheter aortic valve replacement.
2017-09-2003 minTalking PointsEpisode 29: ILLUMENATE USC. Michael Gibson sits down with Sean Lyden to discuss the results.
2017-09-0602 minTalking PointsEpisode 28: The AMULET OBSERVATIONAL STUDYC. Michael Gibson speaks with David Hildick-Smith about left atrial closure devices for stroke prevention.
2017-09-0605 min
Heart podcastLife on the conference trail - an ESC 2017 preview show with Shelley Wood from TCTMD.comIn this episode of the Heart podcast, Digital Media Editor Dr. James Rudd is joined by Shelley Wood, a journalist and managing editor of TCTMD.com. They discuss how to get the most from a medical conference, what’s going to be big at ESC 2017 and why you should always pack your running shoes in your conference bag.
Link to TCTMD: https://www.tctmd.com/
2017-08-2313 min
Heart PodcastLife on the conference trail - an ESC 2017 preview show with Shelley Wood from TCTMD.comIn this episode of the Heart podcast, Digital Media Editor Dr. James Rudd is joined by Shelley Wood, a journalist and managing editor of TCTMD.com. They discuss how to get the most from a medical conference, what’s going to be big at ESC 2017 and why you should always pack your running shoes in your conference bag.
Link to TCTMD: https://www.tctmd.com/
2017-08-2213 minTalking PointsEpisode 27: The WATCHMAN US Postapproval StudyC. Michael Gibson reviews the results with Vivek Reddy.
2017-08-1505 minTalking PointsEpisode 26: PARTNER 1 5-YEAR ECHO - Long-term Hemodynamic and Structural OutcomesC. Michael Gibson discusses the trial findings with Pamela Douglas.
2017-08-0205 min